PPARγ对抗剂通过调节铁和硫脱来表现出抗瘤效应
Shiyu Zhang1, Ying Wang1, Junjie Gu1
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
在口腔状细胞癌 (OSCC) 中准PPARγ会诱导铁和硫化. 这种双细胞死亡机制抑制了瘤的进展,促进了抗瘤免疫力,为OSCC提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 口腔状细胞癌 (OSCC) 是一种主要的头癌,结果不佳.
- 过氧体增殖器激活受体玛 (PPARγ) 与瘤发展有关,但其在OSCC中的确切作用尚不清楚.
研究的目的:
- 调查PPARγ在OSCC发展中的作用,并探索其作为治疗点的潜力.
- 阐明PPARγ抑制影响OSCC细胞死亡途径的机制.
主要方法:
- 采用了转录组测序,传输电子显微镜,铁检测试验,qPCR和西式涂抹.
- 在体内研究中使用了一种小鼠舌头正管移植瘤模型,并进行流动细胞计和免疫组织化学染色.
主要成果:
- 在OSCC细胞中,PPARγ抑制引发了铁和脱硫.
- 抑制PPARγ可以提高HMOX1 (促进铁亡) 和SLC7A11 (促进二硫亡) 的调节.
- 抑制PPARγ导致cDC和CD8+T细胞聚合增加,并在体内抑制OSCC进展.
结论:
- 在OSCC中,PPARγ在调节铁和二硫中起着至关重要的作用.
- 向PPARγ代表了口腔状细胞癌的有希望的治疗策略,通过诱导双细胞死亡和增强抗瘤免疫力.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Abnormal Proliferation
Drugs that Stabilize Microtubules
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
